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Throughout the last decade, our under-
standing of the mechanisms involved
in gene regulation has increased enor-
mously, no more so than the role of
non-coding RNAs (ncRNAs) in the regu-
lation of gene expression (Cech and Steitz,
2014). In particular, a class of small ncR-
NAs, known as microRNAs (miRNAs),
has emerged as having a central role
in the post-transcriptional regulation of
gene expression for a broad range of bio-
logical processes. The early discovery of
muscle-specific miRNAs portended their
importance in myogenesis, myopathies
and adaptation to various forms of exer-
cise (Lagos-Quintana et al., 2002). This
timely Special Topic series summarizes the
findings of studies investigating the func-
tion of miRNAs in skeletal muscle dis-
ease, aging and in response to exercise.
Importantly, the series highlights impor-
tant, unanswered questions in the field
while also speculating on potential new
functions for miRNAs in skeletal muscle
biology.
Zacharewicz and colleagues provide a
comprehensive review of studies that have
described changes in miRNA expression
following exercise, with different mus-
cular disorders and aging (Zacharewicz
et al., 2013). As clearly laid out in Table 1
of their review, numerous studies have
reported changes in both muscle-specific
miRNAs, known as myomiRs, and ubiq-
uitously expressed miRNAs in response
to both an acute bout of exercise, either
resistance or endurance, and following
training. A survey of Table 1 reveals,
in general, that myomiR expression is
increased following a bout of exercise
whereas myomiR expression appears to
be down-regulated with training, though
exceptions to this pattern are shown.
Although fewer studies have reported on
the expression of non-myomiRs, these
studies showed no consistent change in
the miRNA expression pattern in response
to either endurance or resistance exercise.
In contrast to the findings from the exer-
cise studies, miRNA expression profiling
of various human myopathies identified
a common set of miRNA that were up-
regulated in each of the different muscular
disorders. Subsequent studies found that
myomiRs expression is altered in muscular
dystrophy; myomiR-206 was shown to be
dysregulated in both Duchene’s muscular
dystrophy and themdxmousemodel, con-
sistent with the finding of Liu and cowork-
ers that miR-206 knockout mouse shows
an early onset of the dystrophic pheno-
type (Liu et al., 2012). Unfortunately, very
few studies have examined the role of miR-
NAs in skeletal muscle aging but a study
by Drummond and colleagues reported
that let-7 miRNA expression was ele-
vated in skeletal muscle of older humans
(Drummond et al., 2010). The significance
of this finding remains to be explored but
given the anti-poliferative function of let-7
in the worm, the increase in let-7 expres-
sion may be a contributing factor to the
alteration in satellite cell activity observed
with age.
True to the early prediction that miR-
NAs would have a role in skeletal mus-
cle, Sharma and coworkers provide a
concise overview of myomiR function in
myogenesis (Sharma et al., 2014). The
canonical myomiRs miR-1 and miR-206
promote myoblast differentiation whereas,
in contrast, miR-133a enhances myoblast
differentiation. Importantly, how these
miRNAs impact myogenesis is better
understood than the aforementioned exer-
cise studies because the target genes have
been identified. In addition to myogen-
esis, the authors provide a list of miR-
NAs, and relevant target genes in Table 1
that have been reported to have a role
in exercise, atrophy, aging and muscular
dystrophy. The section covering miRNAs
in muscle atrophy highlights the central
role that miRNA have in regulating known
pathways involved in atrophy. This is epit-
omized by the finding that the expression
of the muscle-specific ubiquitin ligases
Atrogin-1 and MuRF are regulated by
miR-23a and, further, that myomiR-486
targets FoxO1 and PTEN, both upstream
regulators of these known atrogenes. A
review of the miRNA aging literature,
offered evidence to suggest that miRNAs
may have a role in maintaining the skeletal
muscle phenotype and mass as well as lim-
iting inflammatory cytokine production.
Future studies will need to determine if the
manipulation of miRNA expression is in
fact able to ameliorate the loss of skeletal
muscle function and mass known to occur
with aging.
Hitachi and Tsuchida provide a focused
discussion on miRNA regulation of sig-
naling pathways involved skeletal mus-
cle hypertrophy (Hitachi and Tsuchida,
2014). As nicely displayed in Figure 1
of their review, it is clear that myomiRs
directly target components of the IGF-
1/Akt/mTOR signaling pathway, the pri-
mary pathway known to regulate skeletal
muscle hypertrophy. In particular, miR-1
has been shown to regulate expression of
IGF-1 while miR-133 has been confirmed
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to target the IGF-1 receptor; consistent
with these findings is the down-regulation
of these myomiRs in response to a hyper-
trophic stimulus presumably contributing
to enhanced IGF-1 signaling, thus help-
ing to promote muscle growth (McCarthy
and Esser, 2007). While shown to be
involved in muscle atrophy, the muscle-
specific miR-486 is proposed to have a
role in muscle hypertrophy through tar-
geting of PTEN, a well-established neg-
ative regulator of Akt activity. Based on
work in the heart, the authors suggest the
reasonable possibility that miR-208b and
miR-499, members of the myomiR net-
work as described by the Olson labora-
tory, have the potential to induce muscle
hypertrophy through regulation of myo-
statin, a validated target gene (van Rooij
et al., 2009). As pointed out by these
authors, a better understanding of the
exact role of miRNAs in the regulation
of skeletal muscle mass will require the
use of genetic models to disrupt miR-
NAs expression within the adult animal
without affecting embryonic or post-natal
development.
Nielsen et al. investigated the regula-
tion of myomiRs in skeletal muscle aging
(Nielsen et al., 2014). In human sub-
jects, expression of miR-1 and 133a/b
were found to be higher in older men
compared to young men, and more-
over, that miR-133a/b expression was
further enhanced in old women. Based
on these findings the authors tested the
hypothesis that miR-133a/b expression
is regulated by testosterone. In agree-
ment with their hypothesis, evidence
was presented showing that miR-133a/b
expression was responsive to changes in
testosterone levels in human and mouse
skeletal muscle; however, additional data
was presented showing that aerobic exer-
cise appeared to independently regulate
myomiR expression and that it was
dominant to the effect of testosterone.
As suggested by the authors, it would
be interesting to know if the coordinated
regulation of miR-133a/b by testosterone
is direct via the androgen receptor or is
through an alternative mechanism involv-
ing post-transcriptional processing of the
primary miRNA transcript.
Historically, the study of miRNAs has
rightly focused on their intracellular role
in regulating gene expression; however,
there is growing evidence that miRNA
are present in the circulation and are
capable of acting as a paracrine factor.
Aoi and Sakuma review recent studies
that have described circulating miRNAs
(c-miRNAs) and how their levels change
following exercise and under pathologi-
cal conditions (Aoi and Sakuma, 2014).
Although this area of research within the
miRNA field is in its infancy, there is opti-
mism that c-miRNA will be able to serve
as biomarkers of athletic performance,
physical fatigue and evidence of muscular
diseases. To reach this lofty goal cer-
tain technical issues (standardized sam-
pling and normalization) will have to be
resolved as well as a better understand-
ing of the mechanism of miRNA secretion
and uptake by target cells. The studies
on c-miRNAs, together with the studies
reviewed in this Special Topics series, leave
little doubt that miRNAs have not only an
important role in skeletal muscle health
and disease but also systemic health as
well.
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